Extended projects support ongoing research into computational approaches and new approach methodologies for food and chemical safety assessment
NEW YORK , Feb. 8, 2026 /PRNewswire/ --
NEW YORK , Feb. 3, 2026 /PRNewswire/ --
Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”, “SLP”), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today announced...
NEW YORK , Jan. 29, 2026 /PRNewswire/ --
NEW YORK , Jan. 23, 2026 /PRNewswire/ --
Showcases platform momentum, strategic priorities, and long-term value creation outlook
Simulations Plus: Fiscal Q1 Earnings Snapshot
Investor Day on January 21, 2026, to present new product vision and AI solutions
Simulations Plus, Inc. (NASDAQ: SLP) shares lost ground Thursday. The company, a global leader in model-informed ...